CHM ASX · Health Care

Chimeric Therapeutics Ltd

Announcements, last 12 months: 94
Price sensitive, last 12 months: 26
Followed on InvestorPA: Some (Among the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
8 Oct 2026, 4:19 PM	Ceasing to be a substantial holder from MFG
6 Oct 2026, 7:27 PM	Notice of initial substantial holder from MFG
5 Oct 2026, 4:28 PM	Final Director's Interest Notice - LR
5 Oct 2026, 4:27 PM	Final Director's Interest Notice - BG
5 Oct 2026, 4:26 PM	Initial Director's Interest Notice - RM
1 Oct 2026, 10:16 AM	FY2026 Annual Report, creditor update and Board changes
1 Oct 2026, 9:34 AM	Suspension from Quotation Price sensitive
29 Sep 2026, 4:50 PM	Application for quotation of securities - CHM
22 Sep 2026, 12:32 PM	Application for quotation of securities - CHM
4 Sep 2026, 12:22 PM	Application for quotation of securities - CHM

Sign in to see all CHM announcements.

Guidance history

31 Aug 2026	Loss from ordinary activities after tax up 80.3% to $18,809,512
29 Jul 2026	None

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow CHM to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.